Central nervous system safety and tolerability of DS-5565: A randomized, double-blind, placebo-and active comparator-controlled phase II study in diabetic peripheral neuropathic pain

Authors
Category Primary study
JournalNeurology
Year 2014
This article has no abstract
Epistemonikos ID: 33352153031fcf474900ed5116cc0f359932419e
First added on: Feb 06, 2025